Unichem Laboratories Business Update
Unichem Laboratories received five procedural observations from the USFDA following an inspection of its Goa formulation facility. The company plans to respond within 15 days.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
Unichem Laboratories received five procedural observations from the USFDA following an inspection of its Goa formulation facility. The company plans to respond within 15 days.
Unichem Laboratories received a tax order from the Commissioner (Appeals, Thane) for a penalty and interest liability totaling ₹93.66 Crore. The company intends to file an appeal.
Unichem extended the exercise period for 3.75 lakh vested ESOP options from 30-Sep-2026 to 31-Mar-2027. The NRC approved the extension via circular resolution under the 2018 Scheme.
Unichem Laboratories clarified that the recent spurt in trading volume is purely market-driven. The company confirmed it has no undisclosed price-sensitive information to report.
Unichem Laboratories held its 63rd Annual General Meeting on August 11, 2026. The meeting covered the adoption of financial statements and re-appointments of key management personnel.
Unichem Laboratories Ltd reported revenue from operations of ₹632.6 Cr (+20.1% YoY) and net profit of ₹41.5 Cr for Q1 FY27.